Literature DB >> 25063757

Altered VEGF-stimulated Ca2+ signaling in part underlies pregnancy-adapted eNOS activity in UAEC.

Derek S Boeldt1, Mary A Grummer1, Ronald R Magness2, Ian M Bird3.   

Abstract

In pregnancy, the uterine vasculature undergoes dramatic vasodilatory adaptations. Previously, vascular endothelial growth factor (VEGF) has been shown to stimulate endothelial nitric oxide synthase (eNOS) in uterine artery endothelial cells (UAECs) derived from pregnant ewes to a greater extent than those from non-pregnant ewes in a manner not fully explained by changes in the phosphorylation of eNOS. In this study, we used Fura-2 Ca(2+) imaging and arginine-to-citrulline conversion eNOS activity assays to assess the importance of VEGF-stimulated Ca(2+) responses in pregnancy-related changes in NO production in UAEC. In this study, we show that pregnancy-induced changes in VEGF-stimulated Ca(2+) responses could account in part for the greater capacity of VEGF to stimulate eNOS in UAECs from pregnant versus non-pregnant animals. VEGF-stimulated Ca(2+) responses in UAECs from pregnant and non-pregnant animals were mediated through VEGF receptor 2 and were detected in roughly 15% of all cells. There were no pregnancy-specific differences in area under the curve or peak height. UAECs from pregnant animals were more consistent in the time to response initiation, had a larger component of extracellular Ca(2+) entry, and were more sensitive to a submaximal dose of VEGF. In UAECs from pregnant and non-pregnant animals Ca(2+) responses and eNOS activation were sensitive to the phospholipase C/inositol 1,4,5-trisphosphate pathway inhibitors 2-aminoethoxydiphenylborane and U73122. Thus, changes in VEGF-stimulated [Ca(2+)]i are necessary for eNOS activation in UAECs, and pregnancy-induced changes in Ca(2+) responses could also in part explain the pregnancy-specific adaptive increase in eNOS activity in UAECs.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  VEGF; adaptation; endothelium; pregnancy

Mesh:

Substances:

Year:  2014        PMID: 25063757      PMCID: PMC4161637          DOI: 10.1530/JOE-14-0252

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  22 in total

1.  Pregnancy-specific enhancement of agonist-stimulated ERK-1/2 signaling in uterine artery endothelial cells increases Ca(2+) sensitivity of endothelial nitric oxide synthase as well as cytosolic phospholipase A(2).

Authors:  T Di; J A Sullivan; R R Magness; L Zhang; I M Bird
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

2.  Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells.

Authors:  I M Bird; J A Sullivan; T Di; J M Cale; L Zhang; J Zheng; R R Magness
Journal:  Endocrinology       Date:  2000-03       Impact factor: 4.736

Review 3.  Nitric oxide and pregnancy.

Authors:  S M Sladek; R R Magness; K P Conrad
Journal:  Am J Physiol       Date:  1997-02

Review 4.  Eicosanoids in preeclampsia.

Authors:  Scott W Walsh
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-02       Impact factor: 4.006

5.  Phosphoinositide 3-kinase regulates phospholipase Cgamma-mediated calcium signaling.

Authors:  L E Rameh; S G Rhee; K Spokes; A Kazlauskas; L C Cantley; L G Cantley
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

6.  A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.

Authors:  M Meyer; M Clauss; A Lepple-Wienhues; J Waltenberger; H G Augustin; M Ziche; C Lanz; M Büttner; H J Rziha; C Dehio
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

7.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

Authors:  J E Park; H H Chen; J Winer; K A Houck; N Ferrara
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

8.  A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain.

Authors:  S Ogawa; A Oku; A Sawano; S Yamaguchi; Y Yazaki; M Shibuya
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

Review 9.  Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function.

Authors:  Ian M Bird; Lubo Zhang; Ronald R Magness
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-02       Impact factor: 3.619

Review 10.  VEGF signalling: integration and multi-tasking in endothelial cell biology.

Authors:  I Zachary
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  10 in total

1.  Adenoviral transduction of EGFR into pregnancy-adapted uterine artery endothelial cells remaps growth factor induction of endothelial dysfunction.

Authors:  Luca Clemente; Derek S Boeldt; Mary A Grummer; Mayu Morita; Terry K Morgan; Greg J Wiepz; Paul J Bertics; Ian M Bird
Journal:  Mol Cell Endocrinol       Date:  2019-09-21       Impact factor: 4.102

Review 2.  Plasticity of the Maternal Vasculature During Pregnancy.

Authors:  George Osol; Nga Ling Ko; Maurizio Mandalà
Journal:  Annu Rev Physiol       Date:  2019-02-10       Impact factor: 19.318

3.  Phosphorylation of Ser-279/282 and Tyr-265 positions on Cx43 as possible mediators of VEGF-165 inhibition of pregnancy-adapted Ca2+ burst function in ovine uterine artery endothelial cells.

Authors:  Derek S Boeldt; Mary A Grummer; FuXian Yi; Ronald R Magness; Ian M Bird
Journal:  Mol Cell Endocrinol       Date:  2015-05-29       Impact factor: 4.102

Review 4.  Gasotransmitters in pregnancy: from conception to uterine involution.

Authors:  Damian D Guerra; K Joseph Hurt
Journal:  Biol Reprod       Date:  2019-07-01       Impact factor: 4.285

5.  Positive versus negative effects of VEGF165 on Ca2+ signaling and NO production in human endothelial cells.

Authors:  Derek S Boeldt; Jennifer Krupp; Fu-Xian Yi; Nauman Khurshid; Dinesh M Shah; Ian M Bird
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-11-11       Impact factor: 4.733

6.  Changes in Ca2+ Signaling and Nitric Oxide Output by Human Umbilical Vein Endothelium in Diabetic and Gestational Diabetic Pregnancies.

Authors:  Heather A Anaya; Fu-Xian Yi; Derek S Boeldt; Jennifer Krupp; Mary A Grummer; Dinesh M Shah; Ian M Bird
Journal:  Biol Reprod       Date:  2015-07-22       Impact factor: 4.285

Review 7.  Uteroplacental Circulation in Normal Pregnancy and Preeclampsia: Functional Adaptation and Maladaptation.

Authors:  Xiangqun Hu; Lubo Zhang
Journal:  Int J Mol Sci       Date:  2021-08-11       Impact factor: 5.923

8.  Cytokine concentrations direct endothelial function in pregnancy and preeclampsia.

Authors:  Amanda K Mauro; Nauman Khurshid; Danielle M Berdahl; Amanda C Ampey; Daniel Adu; Dinesh M Shah; Derek S Boeldt
Journal:  J Endocrinol       Date:  2021-02       Impact factor: 4.286

Review 9.  Endothelial Ca2+ Signaling and the Resistance to Anticancer Treatments: Partners in Crime.

Authors:  Francesco Moccia
Journal:  Int J Mol Sci       Date:  2018-01-11       Impact factor: 5.923

Review 10.  Influence of Estrogens on Uterine Vascular Adaptation in Normal and Preeclamptic Pregnancies.

Authors:  Maurizio Mandalà
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.